Article

  • The EMBO Journal (2003) 22, 4132 - 4142
  • doi:10.1093/emboj/cdg414

Interdimer processing mechanism of procaspase-8 activation

David W. Chang1, Zheng Xing2, Vanessa L. Capacio1, Marcus E. Peter3 and Xiaolu Yang1

  1. Abramson Family Cancer Research Institute and Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
  2. Present address: Department of Molecular and Cell Biology, University of California, Berkley, CA 94720, USA
  3. The Ben May Institute for Cancer Research, University of Chicago, Chicago, IL 60637, USA

Correspondence to:

Xiaolu Yang, E-mail: xyang@mail.med.upenn.edu

Received 22 April 2003; Accepted 2 July 2003; Revised 27 June 2003


The execution of apoptosis depends on the hierarchical activation of caspases. The initiator procaspases become autoproteolytically activated through a less understood process that is triggered by oligomerization. Procaspase-8, an initiator caspase recruited to death receptors, is activated through two cleavage events that proceed in a defined order to generate the large and small subunits of the mature protease. Here we show that dimerization of procaspase-8 produces enzymatically competent precursors through the stable homophilic interaction of the procaspase-8 protease domain. These dimers are also more susceptible to processing than individual procaspase-8 molecules, which leads to their cross-cleavage. The order of the two interdimer cleavage events is maintained by a sequential accessibility mechanism: the separation of the large and small subunits renders the region between the large subunit and prodomain susceptible to further cleavage. In addition, the activation process involves an alteration in the enzymatic properties of caspase-8; while procaspase-8 molecules specifically process one another, mature caspases only cleave effector caspases. These results reveal the key steps leading to the activation of procaspase-8 by oligomerization.

  • Keywords:

    • apoptosis,
    • caspase-8,
    • CD95(Fas/APO-1),
    • interdimer cleavage,
    • oligomerization